Antenatal carbamazepine use associated with d-TGA and ASD [2]

Indian Pediatrics

Volumn 39, Issue 1, 2002, Pages 101-102

  Gupta, Gaurav ^a   Bansal, Arun ^a   Singh, Meenu ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; DIGOXIN; FUROSEMIDE;

ANTICONVULSANT THERAPY; CASE REPORT; CONGENITAL HEART DISEASE; DOSE RESPONSE; DRUG INDUCED DISEASE; EPILEPSY; FETAL ANTICONVULSANT SYNDROME; FETOTOXICITY; GREAT VESSELS TRANSPOSITION; HEART ATRIUM SEPTUM DEFECT; HUMAN; LETTER; MALE; MICROGNATHIA; NEWBORN; PHENOTYPE; PREGNANCY COMPLICATION; PRENATAL CARE; PRENATAL EXPOSURE; SYSTOLIC HEART MURMUR; THORAX RADIOGRAPHY;

ADULT; ANTICONVULSANTS; CARBAMAZEPINE; EPILEPSY; FEMALE; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 0036155976     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Antiepilepsy drugs and the development of congenital anomalies
2. Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine)
3. A multivariate analysis of risk factors for congenital malformations in offsprings of epileptic women
4. Patterns of malformations in the children of women treated with carbamazepine during pregnancy
5. Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy